Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2010-1-28
pubmed:abstractText
The enzyme poly(ADP-ribose) polymerase-1 (PARP-1) is a global monitor of chromatin structure and DNA damage repair. PARP-1 binds to nucleosomes and poly(ADP-ribosylates) histones and several chromatin-associated factors to expose specific DNA sequences to the cellular machinery involved in gene transcription and/or DNA damage repair. While these processes are critical to genomic stability, the molecular mechanisms of how DNA damage induces PARP-1 activation are poorly understood. We have used biochemical and thermodynamic measurements in conjunction with small-angle X-ray scattering to determine the stoichiometry, affinity, and overall structure of a human PARP-1 construct containing the entire DNA binding region, the zinc ribbon domain, and automodification domains (residues 1-486). The interaction of this PARP-1 protein construct with three different DNA damage models (DNA constructs containing a nick, a blunt end, or a 3' extension) was evaluated. Our data indicate that PARP-1 binds each DNA damage model as a monomer and with similar affinity, in all cases resulting in robust activation of the catalytic domain. Using small-angle X-ray scattering, we determined that the N-terminal half of PARP-1 behaves as an extended and flexible arrangement of individually folded domains in the absence of DNA. Upon binding DNA, PARP-1 undergoes a conformational change in the area surrounding the zinc ribbon domain. These data support a model in which PARP-1, upon binding DNA, undergoes a conformational change to become an active nuclear enzyme.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/19962992-10354416, http://linkedlifedata.com/resource/pubmed/commentcorrection/19962992-10455009, http://linkedlifedata.com/resource/pubmed/commentcorrection/19962992-11101525, http://linkedlifedata.com/resource/pubmed/commentcorrection/19962992-12543974, http://linkedlifedata.com/resource/pubmed/commentcorrection/19962992-12829019, http://linkedlifedata.com/resource/pubmed/commentcorrection/19962992-14567702, http://linkedlifedata.com/resource/pubmed/commentcorrection/19962992-14627802, http://linkedlifedata.com/resource/pubmed/commentcorrection/19962992-14686102, http://linkedlifedata.com/resource/pubmed/commentcorrection/19962992-1505517, http://linkedlifedata.com/resource/pubmed/commentcorrection/19962992-15273990, http://linkedlifedata.com/resource/pubmed/commentcorrection/19962992-15647360, http://linkedlifedata.com/resource/pubmed/commentcorrection/19962992-15737996, http://linkedlifedata.com/resource/pubmed/commentcorrection/19962992-15923225, http://linkedlifedata.com/resource/pubmed/commentcorrection/19962992-16262266, http://linkedlifedata.com/resource/pubmed/commentcorrection/19962992-16793420, http://linkedlifedata.com/resource/pubmed/commentcorrection/19962992-17284163, http://linkedlifedata.com/resource/pubmed/commentcorrection/19962992-17322296, http://linkedlifedata.com/resource/pubmed/commentcorrection/19962992-18055453, http://linkedlifedata.com/resource/pubmed/commentcorrection/19962992-18215166, http://linkedlifedata.com/resource/pubmed/commentcorrection/19962992-18452307, http://linkedlifedata.com/resource/pubmed/commentcorrection/19962992-2109322, http://linkedlifedata.com/resource/pubmed/commentcorrection/19962992-3155867, http://linkedlifedata.com/resource/pubmed/commentcorrection/19962992-3918331, http://linkedlifedata.com/resource/pubmed/commentcorrection/19962992-6848489, http://linkedlifedata.com/resource/pubmed/commentcorrection/19962992-7451457, http://linkedlifedata.com/resource/pubmed/commentcorrection/19962992-7460942, http://linkedlifedata.com/resource/pubmed/commentcorrection/19962992-7898458, http://linkedlifedata.com/resource/pubmed/commentcorrection/19962992-8289308
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1089-8638
pubmed:author
pubmed:copyrightInfo
Copyright 2009 Elsevier Ltd. All rights reserved.
pubmed:issnType
Electronic
pubmed:day
5
pubmed:volume
395
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
983-94
pubmed:dateRevised
2011-6-9
pubmed:meshHeading
pubmed-meshheading:19962992-Base Sequence, pubmed-meshheading:19962992-Biophysical Phenomena, pubmed-meshheading:19962992-DNA, pubmed-meshheading:19962992-DNA Damage, pubmed-meshheading:19962992-DNA Primers, pubmed-meshheading:19962992-Enzyme Activation, pubmed-meshheading:19962992-Humans, pubmed-meshheading:19962992-Light, pubmed-meshheading:19962992-Macromolecular Substances, pubmed-meshheading:19962992-Models, Molecular, pubmed-meshheading:19962992-Nucleic Acid Conformation, pubmed-meshheading:19962992-Peptide Fragments, pubmed-meshheading:19962992-Poly(ADP-ribose) Polymerases, pubmed-meshheading:19962992-Protein Conformation, pubmed-meshheading:19962992-Protein Structure, Tertiary, pubmed-meshheading:19962992-Recombinant Proteins, pubmed-meshheading:19962992-Scattering, Small Angle, pubmed-meshheading:19962992-Thermodynamics, pubmed-meshheading:19962992-X-Ray Diffraction
pubmed:year
2010
pubmed:articleTitle
Structural and biophysical studies of human PARP-1 in complex with damaged DNA.
pubmed:affiliation
Department of Biochemistry and Molecular Biology, Colorado State University, Howard Hughes Medical Institute, Fort Collins, CO 80523, USA.
pubmed:publicationType
Journal Article, In Vitro, Research Support, U.S. Gov't, Non-P.H.S., Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural